USA, Calypso Medical Closes $50 Million Venture Financing Round

Calypso Medical Technologies, a Seattle-based developer of real-time localization technology used for the precise tracking of tumor targets, completed a $50m round of venture capital financing. It was led by Skyline Ventures and Frazier Healthcare Ventures with the participation from new investors Bay City Capital and InterWest Partners.
The funds will be used to support the Company’s commercial expansion, both domestically and internationally, and the development of products to support new clinical indications and the continued integration of its systems with existing linear accelerators and other radiation therapy technologies.
Eric Meier, President and Chief Executive Officer of Calypso Medical, was reportes as saying: “With the completion of this financing, we are well capitalized and positioned to further expand the presence of our product platform to leading cancer centers around the globe”.

Join the discussion